Aster DM Healthcare Shareholders' and Creditors' Meetings on March 10, 2026
Aster DM Healthcare Limited will hold meetings for Equity Shareholders and Unsecured Creditors on March 10, 2026, to approve the Scheme of Amalgamation with Quality Care India Limited. All meetings will be virtual, with remote e-voting available from March 6-9, 2026.
The amalgamation of Quality Care India Limited and Aster DM Healthcare Limited is a significant corporate action that could have a material impact on the combined entity's operations, market position, and financial performance.
The announcement is a procedural update regarding the amalgamation process and does not contain new financial information or significant business developments that would impact the sentiment.
Aster DM Healthcare Limited has announced that meetings for its Equity Shareholders and Unsecured Creditors will be held on March 10, 2026. These meetings are being convened pursuant to the directions of the National Company Law Tribunal (NCLT), Hyderabad Bench, dated January 21, 2026.
The purpose of these meetings is to consider and, if thought fit, approve the Scheme of Amalgamation amongst Quality Care India Limited (Transferor Company) and Aster DM Healthcare Limited (Transferee Company), along with their respective shareholders and creditors.
Meetings for Quality Care India Limited's Equity Shareholders and Unsecured Trade Creditors will be held at 10:00 AM and 2:00 PM respectively. For Aster DM Healthcare Limited, meetings for Equity Shareholders and Unsecured Trade Creditors will be held at 10:00 AM and 2:00 PM respectively. All meetings will be conducted virtually through the NSOL platform.
Remote e-voting will be available from March 6, 2026, to March 9, 2026. The scheme of amalgamation is in accordance with Sections 230 to 232 of the Companies Act, 2013.
What to do with a filing like this
Aster DM Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aster DM Healthcare Limited. Read the original for the full detail.